An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss

被引:52
作者
Hampton, David W. [1 ]
Anderson, Jane [1 ]
Pryce, Gareth [2 ]
Irvine, Karen-Amanda [4 ]
Giovannoni, Gavin [2 ]
Fawcett, James W. [1 ]
Compston, Alastair [1 ]
Franklin, Robin J. M. [1 ,3 ]
Baker, David [2 ]
Chandran, Siddharthan [1 ]
机构
[1] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England
[2] Queen Mary Univ London, Inst Cell & Mol Sci, Ctr Neurosci, London E1 2AT, England
[3] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
[4] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA
关键词
Experimental autoimmune encephalomyelitis; Multiple sclerosis; Remyelination; Gliosis; Axon;
D O I
10.1016/j.jneuroim.2008.05.034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) represents a considerable challenge to experimentally model due to its twin pathologies of inflammatory demyelination and neurodegeneration along with its multifocal and multiphasic nature. Experimental autoimmune encephalomyelitis ( I EAE) in Biozzi ABH mice has previously been shown to reproduce Many clinical features also found in secondary progressive MS. In this Study we sought to characterise the pathology of chronic EAE in ABH mice. In addition to Marked gliosis, we report Substantial demyelination, remyelination and axonal and neuronal loss, Together with the clinical pattern, Our findings identify chronic EAE as an excellent model of secondary progressive Multiple sclerosis. (c) 2008 Elsevier B.V All rights reserved.
引用
收藏
页码:200 / 211
页数:12
相关论文
共 57 条
  • [1] A role for caspase-1 and-3 in the pathology of experimental allergic encephalomyelitis -: Inflammation versus degeneration
    Ahmed, Z
    Doward, AI
    Pryce, G
    Taylor, DL
    Pocock, JM
    Leonard, JP
    Baker, D
    Cuzner, ML
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) : 1577 - 1586
  • [2] Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses
    Alvarez, FJ
    Villalba, RM
    Zerda, R
    Schneider, SP
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 472 (03) : 257 - 280
  • [3] Biozzi mice: Of mice and human neurological diseases
    Amor, S
    Smith, PA
    't Hart, B
    Baker, D
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2005, 165 (1-2) : 1 - 10
  • [4] TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
    Arnett, HA
    Mason, J
    Marino, M
    Suzuki, K
    Matsushima, GK
    Ting, JPY
    [J]. NATURE NEUROSCIENCE, 2001, 4 (11) : 1116 - 1122
  • [5] bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS
    Arnett, HA
    Fancy, SPJ
    Alberta, JA
    Zhao, C
    Plant, SR
    Kaing, S
    Raine, CS
    Rowitch, DH
    Franklin, RJM
    Stiles, CD
    [J]. SCIENCE, 2004, 306 (5704) : 2111 - 2115
  • [6] INDUCTION OF CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN BIOZZI MICE
    BAKER, D
    ONEILL, JK
    GSCHMEISSNER, SE
    WILCOX, CE
    BUTTER, C
    TURK, JL
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1990, 28 (03) : 261 - 270
  • [7] Cannabinoids control spasticity and tremor in a multiple sclerosis model
    Baker, D
    Pryce, G
    Croxford, JL
    Brown, P
    Pertwee, RG
    Huffman, JW
    Layward, L
    [J]. NATURE, 2000, 404 (6773) : 84 - 87
  • [8] Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia
    Bannerman, Peter
    Hahn, Ashleigh
    Soulika, Athena
    Gallo, Vittorio
    Pleasure, David
    [J]. GLIA, 2007, 55 (01) : 57 - 64
  • [9] Efficient central nervous system remyelination requires T cells
    Bieber, AJ
    Kerr, S
    Rodriguez, M
    [J]. ANNALS OF NEUROLOGY, 2003, 53 (05) : 680 - 684
  • [10] The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors
    Blakemore, WF
    Gilson, JA
    Crang, AJ
    [J]. EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 955 - 963